These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2101778)

  • 1. CTX and its desacetyl derivative (des-CTX): interaction with some representative beta-lactamases and their related pattern of resistance to newer selected clinical isolates.
    Amicosante G; Perilli M; Felici A; Segatore B; Franceschini N; Basani F; Di Girolamo M; Oratore A
    Drugs Exp Clin Res; 1990; 16(11):549-56. PubMed ID: 2101778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
    Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro studies on cefotaxime and desacetylcefotaxime.
    Selwyn S; Bakhtiar M
    Drugs Exp Clin Res; 1986; 12(12):953-65. PubMed ID: 3494587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
    Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
    Aldridge KE; Sanders CV; Marier RL
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population analysis of susceptibility to cefotaxime and desacetyl-cefotaxime in Staphylococcus and Enterobacteriaceae.
    Hansen BG; Søgaard P
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):243-7. PubMed ID: 3875967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
    Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
    J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of combined cefotaxime and desacetyl-cefotaxime against aerobic and anaerobic gram-negative bacilli.
    Marone P; Navarra A; Monzillo V; Traverso A
    Drugs Exp Clin Res; 1990; 16(12):629-33. PubMed ID: 2130005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and beta-lactamase stability.
    Limbert M; Seibert G; Schrinner E
    Infection; 1982; 10(2):97-100. PubMed ID: 6284653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
    Reller LB
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
    Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
    J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R; Nightingale CH; Tilton R
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime.
    Winstanley TG; Spencer RC
    Drugs Exp Clin Res; 1986; 12(12):967-71. PubMed ID: 3471432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.
    Pitout JD; Hossain A; Hanson ND
    J Clin Microbiol; 2004 Dec; 42(12):5715-21. PubMed ID: 15583304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MICs and MBCs of cefotaxime, desacetylcefotaxime and ceftriaxone against four principal bacteria causing meningitis].
    Deguchi K; Fukuyama S; Nishimura Y; Nishike A; Fukumoto T; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N
    Jpn J Antibiot; 1984 Sep; 37(9):1701-13. PubMed ID: 6096585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cefotaxime alone and in combination with desacetylcefotaxime against strains of Staphylococcus aureus that produce variants of staphylococcal beta-lactamase.
    Stratton CW; Kernodle DS; Eades SC; Weeks LS
    Diagn Microbiol Infect Dis; 1989; 12(1):57-65. PubMed ID: 2785444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of beta-lactamases on desacetyl-cefotaxime and cefotaxime.
    Labia R; Morand A; Kazmierczak A
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():45-51. PubMed ID: 6094462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.